National Cancer Institute; Notice of Closed Meetings, 5456-5457 [2020-01737]
Download as PDF
<![CDATA[
5456
Federal Register / Vol. 85, No. 20 / Thursday, January 30, 2020 / Notices
benefits both the participants and the
underserved communities–especially in
our Federally Qualified Health Centers
which support many of our Nurse Corps
Nurse Practitioners.
Updated Form #2—The Nurse Corps
LRP application will include questions
for applicants to provide information
regarding telehealth services, multiple
CSF sites, and verification of base salary
to determine the debt to salary ratio
used to rank applicants for award
consideration. The application will also
be updated to identify applicants
eligible for Nurse Corps LRP psychiatric
nurse practitioner funding.
Likely Respondents: Professional RNs
or advanced practice RNs who are
interested in participating in the Nurse
Corps LRP and official representatives at
their service sites.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
Number of
respondents
Form name
Number of
responses per
respondent
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel to be able to respond to a
collection of information; to search data
sources; to complete and review the
collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
Total Estimated Annualized Burden
Hours: The estimates of reporting
burden for Applications are as follows:
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Nurse Corps LRP Application * ............................................
Authorization to Release Information Form * * .....................
Employment Verification Form * * .........................................
Disadvantaged Background Form .......................................
Confirmation of Interest Form ..............................................
7,100
7,100
7,100
450
500
1
1
1
1
1
7,100
7,100
7,100
450
500
2.00
.10
.10
.20
.20
14,200
710
710
90
100
Total for Applicants .......................................................
22,250
........................
22,250
........................
15,810
* The burden hours associated with this instrument account for both new and continuation applications. Additional (uploaded) supporting documentation is included as part of this instrument and is reflected in the burden hours.
* * The same respondents are completing these instruments.
The estimates of reporting for
Participants are as follows:
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Participant Semi-Annual In Service Verification Form ........
Nurse Corps CSF Verification Form ....................................
Nurse Corps Nurse Faculty Employment Verification Form
500
500
450
2
1
1
1,000
500
450
.50
.10
.20
500
50
90
Total for Participants .....................................................
1,450
........................
1,950
........................
640
Total for Applicants and Participants ....................
23,700
........................
24,200
........................
* 16,450
* The 16,450 figure is the sum of total burden hours for applicants and participants. This revision adds an additional form (the Disadvantaged
Background Form).
Maria G. Button,
Director, Executive Secretariat.
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2020–01713 Filed 1–29–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
VerDate Sep<11>2014
16:56 Jan 29, 2020
Jkt 250001
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–12:
SBIR, Contract Review Meeting.
Date: March 3, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W236, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Robert Stephen Coyne,
Ph.D., Scientific Review Officer, National
Cancer Institute, NIH, Division of Extramural
Activities, Special Review Branch, 9609
Medical Center Drive, Room 7W236,
Rockville, MD 20850, 240–276–5120,
coyners@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI U01
Review.
Date: March 17, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W514, Rockville, MD 20850, (Telephone
Conference Call).
E:\FR\FM\30JAN1.SGM
30JAN1
Federal Register / Vol. 85, No. 20 / Thursday, January 30, 2020 / Notices
Contact Person: Wlodek Lopaczynski,
M.D., Ph.D., Assistant Director, Office of the
Director, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W514, Rockville, MD
20892, 240–276–6458, lopacw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Informatics Technology.
Date: April 16–17, 2020.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Reed A. Graves, Ph.D.,
Scientific Review Officer, 9609 Medical
Center Drive, Room 7W264, Division of
Extramural Activities, Research Technology
and Contract Review Branch, National
Cancer Institute, NIH, Rockville, MD 20850,
(240) 276–6384, gravesr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 27, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01737 Filed 1–29–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; GEMSSTAR.
Date: March 2, 2020.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
16:56 Jan 29, 2020
Jkt 250001
Place: Bethesda Marriott, Conference Room
Montgomery/Democracy, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Isis S. Mikhail, MD, MPH,
DrPH, Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building 2C212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, Tel: (301) 402–7704,
mikhaili@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: January 24, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01637 Filed 1–29–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
5457
Date: February 28, 2020.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Ipolia R Ramadan, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, Room 4228, MSC 95509529,
Bethesda, MD 20892, ramadanir@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 27, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01742 Filed 1–29–20; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Leveraging Big Data Science to Elucidate the
Neural Mechanisms of Addiction and
Substance Use Disorder.
Date: February 26, 2020.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4238, MSC 9550, Bethesda, MD 20892, 301–
402–6020, hiromi.ono@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Exploiting Genome or Epigenome Editing to
Functionally Validate Genes or Variants
Involved in Substance Use Disorders (R21/
R33) Clinical Trial Not Allowed.
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Immunobiology of
Xenotransplantation (U01/U19, Clinical Trial
Not Allowed).
Date: February 24–25, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892, (Virtual
Meeting).
Contact Person: Zhuqing (Charlie) Li,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G41B,
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 85, Number 20 (Thursday, January 30, 2020)]
[Notices]
[Pages 5456-5457]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01737]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-12: SBIR, Contract Review Meeting.
Date: March 3, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W236, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Robert Stephen Coyne, Ph.D., Scientific Review
Officer, National Cancer Institute, NIH, Division of Extramural
Activities, Special Review Branch, 9609 Medical Center Drive, Room
7W236, Rockville, MD 20850, 240-276-5120, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI U01 Review.
Date: March 17, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W514, Rockville, MD 20850, (Telephone Conference
Call).
[[Page 5457]]
Contact Person: Wlodek Lopaczynski, M.D., Ph.D., Assistant
Director, Office of the Director, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W514, Rockville, MD 20892, 240-276-6458, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Informatics Technology.
Date: April 16-17, 2020.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Reed A. Graves, Ph.D., Scientific Review
Officer, 9609 Medical Center Drive, Room 7W264, Division of
Extramural Activities, Research Technology and Contract Review
Branch, National Cancer Institute, NIH, Rockville, MD 20850, (240)
276-6384, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: January 27, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-01737 Filed 1-29-20; 8:45 am]
BILLING CODE 4140-01-P
